These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 32988822

  • 1. A Population Pharmacokinetic Analysis of Continuous Infusion of Cloxacillin during Staphylococcus aureus Bone and Joint Infections.
    Courjon J, Garzaro M, Roger PM, Ruimy R, Lavrut T, Chelli M, Raynier JL, Chirio D, Demonchy E, Cabane L, Jehl F, Trojani C, Grillon A, Goutelle S.
    Antimicrob Agents Chemother; 2020 Nov 17; 64(12):. PubMed ID: 32988822
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Is continuous infusion of imipenem always the best choice?
    Suchánková H, Lipš M, Urbánek K, Neely MN, Strojil J.
    Int J Antimicrob Agents; 2017 Mar 17; 49(3):348-354. PubMed ID: 28189734
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of free ertapenem in critically ill septic patients: intermittent versus continuous infusion.
    Breilh D, Fleureau C, Gordien JB, Joanes-Boyau O, Texier-Maugein J, Rapaport S, Boselli E, Janvier G, Saux MC.
    Minerva Anestesiol; 2011 Nov 17; 77(11):1058-62. PubMed ID: 21597443
    [Abstract] [Full Text] [Related]

  • 5. Probability of target attainment for ceftobiprole as derived from a population pharmacokinetic analysis of 150 subjects.
    Lodise TP, Pypstra R, Kahn JB, Murthy BP, Kimko HC, Bush K, Noel GJ, Drusano GL.
    Antimicrob Agents Chemother; 2007 Jul 17; 51(7):2378-87. PubMed ID: 17387149
    [Abstract] [Full Text] [Related]

  • 6. Population pharmacokinetics at two dose levels and pharmacodynamic profiling of flucloxacillin.
    Landersdorfer CB, Kirkpatrick CM, Kinzig-Schippers M, Bulitta JB, Holzgrabe U, Drusano GL, Sörgel F.
    Antimicrob Agents Chemother; 2007 Sep 17; 51(9):3290-7. PubMed ID: 17576847
    [Abstract] [Full Text] [Related]

  • 7. Continuous infusion of ceftolozane/tazobactam is associated with a higher probability of target attainment in patients infected with Pseudomonas aeruginosa.
    Pilmis B, Petitjean G, Lesprit P, Lafaurie M, El Helali N, Le Monnier A, on behalf the ATB PK/PD study group.
    Eur J Clin Microbiol Infect Dis; 2019 Aug 17; 38(8):1457-1461. PubMed ID: 31073653
    [Abstract] [Full Text] [Related]

  • 8. Impact of Key Components of Intensified Ceftaroline Dosing on Pharmacokinetic/Pharmacodynamic Target Attainment.
    Minichmayr IK, Wicha SG, Matzneller P, Kloft C, Zeitlinger M.
    Clin Pharmacokinet; 2024 Jan 17; 63(1):121-131. PubMed ID: 38007714
    [Abstract] [Full Text] [Related]

  • 9. Population Pharmacokinetics of Flucloxacillin In Bone and Soft Tissue- Standard Dosing is Not Sufficient to Achieve Therapeutic Concentrations.
    Öbrink-Hansen K, Pham AD, Bue M, Hanberg P, Bendtsen M, Slater J, Friberg LE, Thorsted A, Stilling M.
    Pharm Res; 2022 Jul 17; 39(7):1633-1643. PubMed ID: 35233728
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pharmacokinetic and Pharmacodynamic Analyses of Ceftaroline in Adults with Cystic Fibrosis.
    Autry EB, Rybak JM, Leung NR, Gardner BM, Burgess DR, Anstead MI, Kuhn RJ.
    Pharmacotherapy; 2016 Jan 17; 36(1):13-8. PubMed ID: 26748559
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of conventional dosing versus continuous-infusion vancomycin therapy for patients with suspected or documented gram-positive infections.
    James JK, Palmer SM, Levine DP, Rybak MJ.
    Antimicrob Agents Chemother; 1996 Mar 17; 40(3):696-700. PubMed ID: 8851595
    [Abstract] [Full Text] [Related]

  • 16. Population pharmacokinetics and probability of target attainment of ertapenem administered by subcutaneous or intravenous route in patients with bone and joint infection.
    Goutelle S, Valour F, Gagnieu MC, Laurent F, Chidiac C, Ferry T, Lyon Bone and Joint Infection Study Group.
    J Antimicrob Chemother; 2018 Apr 01; 73(4):987-994. PubMed ID: 29244077
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of omadacycline regimens for community-acquired bacterial pneumonia patients infected with Staphylococcus Aureus by pharmacokinetic/pharmacodynamic analysis.
    Xu G, Liu X, Wang J, Mei Y, Yang D, He C, Zhong L, Zhu J, Ding H, Fang L.
    J Chemother; 2024 Dec 01; 36(8):709-716. PubMed ID: 38650393
    [Abstract] [Full Text] [Related]

  • 18. Comparative pharmacodynamics of intermittent and prolonged infusions of piperacillin/tazobactam using Monte Carlo simulations and steady-state pharmacokinetic data from hospitalized patients.
    Shea KM, Cheatham SC, Smith DW, Wack MF, Sowinski KM, Kays MB.
    Ann Pharmacother; 2009 Nov 01; 43(11):1747-54. PubMed ID: 19809009
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetic-pharmacodynamic rationale for cefepime dosing regimens in intensive care units.
    Roos JF, Bulitta J, Lipman J, Kirkpatrick CM.
    J Antimicrob Chemother; 2006 Nov 01; 58(5):987-93. PubMed ID: 16943209
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.